Journal article
Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes
Abstract
BACKGROUND: Stopping renin-angiotensin system inhibitors (RASi) after an episode of hyperkalemia is common but may involve therapeutic compromises, in that the cessation of RASi deprives patients of their beneficial cardiovascular effects.
METHODS AND RESULTS: Observational study from the Stockholm Creatinine Measurements (SCREAM) project including patients initiating RASi in routine care and surviving a first-detected episode of hyperkalemia …
Authors
Xu Y; Fu EL; Trevisan M; Jernberg T; Sjölander A; Clase CM; Carrero J-J
Journal
American Heart Journal, Vol. 243, , pp. 177–186
Publisher
Elsevier
Publication Date
January 2022
DOI
10.1016/j.ahj.2021.09.014
ISSN
0002-8703